Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7

Xiangyu Jin(Jiangnan University), Yi Huang(Jiangnan University)
Cell Reports Medicine
December 1, 2023
10.1016/j.xcrm.2023.101310
Cited by 46

Related Papers

Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
|Science Advances|2024|133
The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation
|Frontiers in Pharmacology|2017|9